Figure 1

Percentages of patients with psoriatic arthritis achieving a Physician's Global Assessment (PGA) of "Clear/Almost clear" at baseline and week 12, stratified by history of anti-tumor necrosis factor therapy. Data are observed. IFX, infliximab; ETN, etanercept.